Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery

Anesthesiology

Volumn 90, Issue 1, 1999, Pages 42-53

  Ziser, Avishai ^a,b   Plevak, David J ^a   Wiesner, Russell H ^c   Rakela, Jorge ^d   Offord, Kenneth P ^c   Brown, David L ^e  

^a DEPARTMENT OF UROLOGY   (United States)

^b RAMBAM MEDICAL CENTER   (Israel)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Liver disease; Perioperative complications; Risk factors

Indexed keywords

CREATININE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANESTHESIA; ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MORTALITY; PEROPERATIVE COMPLICATION; PNEUMONIA; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SURGERY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANESTHESIA; CREATININE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INTRAOPERATIVE COMPLICATIONS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURGICAL PROCEDURES, OPERATIVE;

EID: 0032615002     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199901000-00008     Document Type: Article

References (35)

1. Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, Caballería J, Rodés J, Rozman C: Compensated cirrhosis: Natural history and prognostic factors. Hepatology 1987; 7:122-8
2. Aranha GV, Sontag SJ, Greenlee HB: Cholecystectomy in cirrhotic patients: A formidable operation. Am J Surg 1982; 143:55-60
3. Japanese Research Society for Portal Hypertension: The general rules for recording endoscopic findings on esophageal varices. Jpn J Surg 1980; 10:84-7
4. Fraser CL, Arieff AI: Hepatic encephalopathy. N Engl J Med 1985; 313:865-73
5. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-9
6. Keats AS: The ASA classification of physical status: A recapitulation. ANESTHESIOLOGY 1978; 49:233
7. The International Classification of Diseases, 9th Revision, Clinical Modification. Volume 3: Procedures. Ann Arbor, MI, Commission on Professional and Hospital Activities, 1978
8. Papper S, Belsky JL, Bleifer KH: Renal failure in Laennec's cirrhosis of the liver. I. Description of clinical and laboratory features. Ann Intern Med 1959; 51:759-73
9. Walker SH, Duncan DB: Estimation of the probability of an event as a function of several independent variables. Biometrika 1967; 54: 167-79
10. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81
11. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports 1966; 50:163-70
12. Leonetti JP, Aranha GV, Wilkinson WA, Stanley M, Greenlee HB: Umbilical herniorrhaphy in cirrhotic patients. Arch Surg 1984; 119: 442-5
13. Rice HE, O'Keefe GE, Helton WS, Johansen K: Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg 1997; 132:880-5
14. Martin JL, Kenna JG, Pohl LR: Antibody assays for the detection of patients sensitized to halothane. Anesth Analg 1990; 70:154-9
15. Martin JL, Kenna JG, Martin BM, Thomassen D, Reed GF, Pohl LR: Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase. Hepatology 1993; 18:858-63
16. Martin JL, Dubbink DA, Plevak DJ, Peronne A, Taswell HF, Hay EJ, Pumford NR, Pohl LR: Halothane hepatitis 28 years after primary exposure. Anesth Analg 1992; 74:605-8
17. Gunaratnam NT, Benson J, Gandolfi AJ, Chen M: Suspected isoflurane hepatitis in an obese patient with a history of halothane hepatitis. ANESTHESIOLOGY 1995; 83:1361-4
18. Martin JL, Plevak DJ, Flannery KD, Charlton M, Poterucha JJ, Humphreys CE, Derfus G, Pohl LR: Hepatotoxicity after desflurane anesthesia. ANESTHESIOLOGY 1995; 83:1125-9
19. Nagao T, Inoue S, Mizuta T, Saito H, Kawano N, Morioka Y: One hundred hepatic resections: Indications and operative results. Ann Surg 1985; 202:42-9
20. Hanson KM, Johnson PC: Local control of hepatic arterial and portal venous flow in the dog. Am J Physiol 1966; 211:712-20
21. Gelman S, Dillard E, Bradley El Jr: Hepatic circulation during surgical stress and anesthesia with halothane, isoflurane, or fentanyl. Anesth Analg 1987; 66:936-43
22. Gholson CF, Provenza JM, Bacon BR: Hepatologic considerations in patients with parenchymal liver disease undergoing surgery. Am J Gastroenterology 1990; 85:487-96
23. McClain C, Hill D, Schmidt J, Diehl AM: Cytokines and alcoholic liver disease. Sem Liver Dis 1993; 13:170-82
24. McGinn PV: Reversal of the haemodynamic features of acute liver failure by methylene blue. Intensive Care Med 1996; 22:612
25. Schneider F, Lutun P, Boudjema K, Wolf P, Tempe JD: In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. Hepatology 1994; 19:38-44
26. Guarner F, Boughton-Smith NK, Blackwell GJ, Moncada S: Reduction by prostacyclin of acetaminophen-induced liver toxicity in the mouse. Hepatology 1988; 8:248-53
27. Abecassis M, Falk JA, Makowka L, Dindzans VJ, Falk RE, Levy GA: 16,16-Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest 1987; 80:881-9
28. de la Mata M, Meager A, Rolando N, Daniels HM, Noun-Aria KT, Goka AKJ, Eddleston ALWF, Alexander GJM, Williams R: Tumour necrosis factor production in fulminant hepatic failure: Relation to aetiology and superimposed microbial infection. Clin Exp Immunol 1990; 82:479-84
29. Muto Y, Nouri-Aria KT, Meager A, Alexander GJM, Eddleston ALWF, Williams R: Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988; ii:72-4
30. Wilkinson SP, Arroyo V, Gazzard BG, Moodie H, Williams R: Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. Lancet 1974; i:521-4
31. Nakagawa K, Matsubara SM, Ouchi K, Owada Y, Yajima Y: Endotoxemia after abdominal surgery. Tohoku J Exp Med 1986; 150: 273-80
32. Fee JP, Black GW, Dundee JW, McIlroy PD, Johnston HM, Johnston SB, Black IH, McNeill HG, Neill DW, Doggart JR, Merrett JD, McDonald JR, Bradley DS, Haire M, McMillan SA: A prospective study of liver enzyme and other changes following repeat administration of halothane and enflurane. Br J Anaesth 1979; 51;1133-41
33. Schlebusch H, Garstka G, Harnack H: The effect of anesthesia on the postoperative behavior of liver enzymes and protein fractions. Fortschritte der Medizin 1977; 95:662-8
34. Gunza JT, Pashayan AG: Postoperative elevation of serum transaminases following isoflurane anesthesia. J Clin Anesth 1992; 4:336-41
35. Concato J, Feinstein AR, Holford TR: The risk of determining risk with multivariable models. Ann Intern Med 1993; 118:201-10